Home / Inspections / 1217918

FDA Inspection 1217918 — Carter BloodCare

Carter BloodCare — FEI 3002603147

The FDA completed an inspection of Carter BloodCare on August 22, 2023 in Bedford, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 22, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Bedford, TX (United States)

Facility

Other inspections at this facility

  • 1093449 (NAI Fri Apr 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1033975 (VAI Wed Dec 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 846717 (NAI Thu Aug 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 736481 (VAI Wed Jul 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 604811 (VAI Mon Aug 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources